ID
14027
Description
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia; ODM derived from: https://clinicaltrials.gov/show/NCT02277847
Link
https://clinicaltrials.gov/show/NCT02277847
Keywords
Versions (1)
- 3/22/16 3/22/16 -
Uploaded on
March 22, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myeloid Leukemia NCT02277847
Eligibility Acute Myeloid Leukemia NCT02277847
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
CML
Data type
boolean
Alias
- UMLS CUI [1]
- C0023473
Description
Myeloproliferative disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0027022
Description
Neoplasms
Data type
boolean
Alias
- UMLS CUI [1]
- C0027651
Description
Organ function
Data type
boolean
Alias
- UMLS CUI [1]
- C1254358
Description
Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Similar models
Eligibility Acute Myeloid Leukemia NCT02277847
- StudyEvent: Eligibility